Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: methylphenidate
Also marketed in the EU under the name(s): Concerta, Elmifiten, Equasym, Medikid, Medikinet, Methylfenidaat, Methylpheni, Methylphenidat, Methylphenidate, Motiron, MPH Novartis, Omozin, Quazym, Ritalin, Ritalina, Rubifen, Tifinidat, Tranquilyn
Active substance: methylphenidate
Indication: Attention-Deficit/Hyperactivity Disorder (ADHD)
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/05/2009 Referral EMEA/H/A-31/886 (2009)4242 of 27/05/2009